Morrissey Michael M.'s most recent trade in Incyte Corp. was a trade of 8,999 Performance Shares done . Disclosure was reported to the exchange on July 23, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Incyte | Michael James Morrissey | EVP, Head of Tech. Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 8,999 | 8,999 | - | - | Performance Shares | |
| Incyte | Michael James Morrissey | EVP, Head of Tech. Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 6,426 | 6,426 | - | - | Employee Stock Option (right to buy) | |
| Vera Therapeutics Inc (Class A) | Michael M. Morrissey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2026 | 17,084 | 17,084 | - | - | Stock Option (right to buy) | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.10 per share. | 15 May 2026 | 128,497 | 1,486,055 (0%) | 0% | 51.1 | 6,566,197 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 15 May 2026 | 124,047 | 2,004,327 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 15 May 2026 | 124,047 | 1,362,008 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 May 2026 | 109,676 | 1,880,280 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2026 | 160,437 | 1,614,552 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Feb 2026 | 100,278 | 1,989,956 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.31 per share. | 13 Feb 2026 | 494,700 | 2,319,941 (0%) | 0% | 21.3 | 10,542,057 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 494,700 | 0 | - | - | Option (right to buy) | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.92 per share. | 13 Feb 2026 | 369,606 | 1,950,335 (0%) | 0% | 43.9 | 16,233,096 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Feb 2026 | 250,736 | 1,579,209 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Feb 2026 | 250,736 | 1,965,140 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Feb 2026 | 125,094 | 2,090,234 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Feb 2026 | 125,094 | 1,454,115 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.92 per share. | 13 Feb 2026 | 120,390 | 1,829,945 (0%) | 0% | 43.9 | 5,287,529 | Common Stock |
| Incyte | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.67 per share. | 02 Feb 2026 | 185 | 34,065 (0%) | 0% | 102.7 | 18,994 | Common Stock |
| Incyte | Michael James Morrissey | EVP, Head of Tech. Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2026 | 7,426 | 34,679 (0%) | 0% | 0 | Common Stock | |
| Incyte | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.62 per share. | 16 Jan 2026 | 429 | 34,250 (0%) | 0% | 102.6 | 44,024 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2026 | 548,073 | 1,964,765 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.23 per share. | 15 Jan 2026 | 139,524 | 1,825,241 (0%) | 0% | 45.2 | 6,310,671 | Common Stock |
| Incyte | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 98.77 per share. | 31 Dec 2025 | 254 | 27,253 (0%) | 0% | 98.8 | 25,088 | Common Stock |
| Incyte | Michael James Morrissey | EVP, Head of Tech. Operations | Sale of securities on an exchange or to another person at price $ 97.29 per share. | 16 Dec 2025 | 53,175 | 31,830 (0%) | 0% | 97.3 | 5,173,396 | Common Stock |
| Incyte | Michael James Morrissey | EVP, Head of Tech. Operations | Sale of securities on an exchange or to another person at price $ 97.26 per share. | 16 Dec 2025 | 4,323 | 27,507 (0%) | 0% | 97.3 | 420,455 | Common Stock |
| Incyte | Michael James Morrissey | EVP, Head of Tech. Operations | Sale of securities on an exchange or to another person at price $ 97.42 per share. | 16 Dec 2025 | 833 | 85,005 (0%) | 0% | 97.4 | 81,151 | Common Stock |
| Incyte | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.04 per share. | 01 Dec 2025 | 326 | 85,838 (0%) | 0% | 102.0 | 33,265 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Nov 2025 | 160,000 | 1,692,856 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Nov 2025 | 101,548 | 1,416,692 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Nov 2025 | 101,548 | 1,794,404 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Nov 2025 | 80,000 | 1,714,404 (0%) | 0% | 0 | Common Stock | |
| Incyte | Michael James Morrissey | EVP, Head of Tech. Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2025 | 10,961 | 10,961 | - | - | Performance Shares | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2025 | 308,365 | 0 | - | - | Option (right to buy) | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.80 per share. | 14 May 2025 | 308,365 | 1,931,374 (0%) | 0% | 18.8 | 5,797,262 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.65 per share. | 14 May 2025 | 220,494 | 1,710,880 (0%) | 0% | 44.6 | 9,845,057 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.65 per share. | 14 May 2025 | 104,769 | 1,606,111 (0%) | 0% | 44.7 | 4,677,936 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 14 May 2025 | 87,871 | 1,518,240 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 14 May 2025 | 87,871 | 1,852,856 (0%) | 0% | 0 | Common Stock | |
| Vera Therapeutics Inc (Class A) | Michael M. Morrissey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 14,000 | 14,000 | - | - | Stock Option (right to buy) | |
| Incyte | Michael James Morrissey | EVP, Head of Tech. Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 4,649 | 86,164 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 589,719 | 1,623,009 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 184,909 | 1,033,290 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Feb 2025 | 177,985 | 848,381 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Feb 2025 | 177,985 | 1,764,985 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.00 per share. | 15 Feb 2025 | 63,570 | 1,026,366 (0%) | 0% | 35 | 2,224,950 | Common Stock |
| Incyte | Michael James Morrissey | EVP, Head of Tech. Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 10,552 | 81,515 (0%) | 0% | 0 | Common Stock | |
| Incyte | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.47 per share. | 21 Jan 2025 | 429 | 70,963 (0%) | 0% | 73.5 | 31,519 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 473,226 | 1,210,180 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.27 per share. | 16 Jan 2025 | 120,244 | 1,089,936 (0%) | 0% | 37.3 | 4,481,494 | Common Stock |
| Incyte | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.46 per share. | 15 Jan 2025 | 908 | 71,392 (0%) | 0% | 72.5 | 65,794 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Dec 2024 | 179,788 | 736,954 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | M. Michael Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Dec 2024 | 179,788 | 1,587,000 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.05 per share. | 15 Nov 2024 | 47,642 | 916,742 (0%) | 0% | 35.0 | 1,669,852 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Oct 2024 | 46,000 | 1,407,212 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.41 per share. | 01 Oct 2024 | 480,000 | 1,444,384 (0%) | 0% | 24.4 | 11,716,800 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 480,000 | 0 | - | - | Option (right to buy) | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.30 per share. | 01 Oct 2024 | 463,702 | 980,682 (0%) | 0% | 26.3 | 12,195,363 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Oct 2024 | 16,298 | 1,453,212 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Oct 2024 | 16,298 | 964,384 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.99 per share. | 15 May 2024 | 39,681 | 964,384 (0%) | 0% | 21.0 | 832,904 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.99 per share. | 15 May 2024 | 34,262 | 1,004,065 (0%) | 0% | 21.0 | 719,159 | Common Stock |
| Vera Therapeutics Inc (Class A) | Michael M. Morrissey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 14,000 | 14,000 | - | - | Stock Option (right to buy) | |
| Exelixis Inc | Morrissey Michael M. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 241,670 | 1,038,327 (0%) | 0% | 0 | Common Stock | |
| Incyte | Morrissey Michael James | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.50 per share. | 22 Jan 2024 | 108 | 72,300 (0%) | 0% | 61.5 | 6,642 | Common Stock |
| Incyte | James Morrissey Michael | EVP, Head of Tech. Operations | Grant, award, or other acquisition of securities at price $ 61.18 per share. | 18 Jan 2024 | 11,359 | 72,530 (0%) | 0% | 61.2 | 694,944 | Common Stock |
| Incyte | Michael Morrissey James | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.49 per share. | 18 Jan 2024 | 122 | 72,408 (0%) | 0% | 61.5 | 7,502 | Common Stock |
| Incyte | Morrissey Michael James | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.48 per share. | 16 Jan 2024 | 101 | 61,171 (0%) | 0% | 61.5 | 6,209 | Common Stock |
| Incyte | Morrissey James Michael | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.34 per share. | 16 Jan 2024 | 101 | 61,272 (0%) | 0% | 61.3 | 6,195 | Common Stock |
| Exelixis Inc | M. Morrissey Michael | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2024 | 250,374 | 860,374 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.86 per share. | 11 Jan 2024 | 63,717 | 796,657 (0%) | 0% | 22.9 | 1,456,571 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.31 per share. | 28 Aug 2023 | 360,000 | 945,496 (0%) | 0% | 15.3 | 5,511,600 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2023 | 360,000 | 0 | - | - | Option (right to buy) | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.18 per share. | 28 Aug 2023 | 303,779 | 641,717 (0%) | 0% | 22.2 | 6,737,818 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.51 per share. | 15 Aug 2023 | 23,304 | 585,496 (0%) | 0% | 21.5 | 501,269 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.18 per share. | 15 May 2023 | 33,518 | 608,800 (0%) | 0% | 19.2 | 642,875 | Common Stock |
| Vera Therapeutics Inc (Class A) | Michael M. Morrissey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 313,185 | 642,318 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.08 per share. | 15 Feb 2023 | 11,522 | 329,133 (0%) | 0% | 18.1 | 208,318 | Common Stock |
| Selective Insurance Grp Inc | Michael J. Morrissey | Director | Sale of securities on an exchange or to another person at price $ 101.21 per share. | 06 Feb 2023 | 4,000 | 12,578 (0%) | 0% | 101.2 | 404,836 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Jan 2023 | 37,994 | 1,340,320 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Jan 2023 | 37,994 | 340,655 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Jan 2023 | 106,010 | 1,302,326 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Jan 2023 | 106,010 | 340,655 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2023 | 100,000 | 0 | - | - | Option (right to buy) | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.20 per share. | 24 Jan 2023 | 100,000 | 440,655 (0%) | 0% | 4.2 | 420,000 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.36 per share. | 24 Jan 2023 | 62,006 | 378,649 (0%) | 0% | 17.4 | 1,076,424 | Common Stock |
| Incyte | Michael James Morrissey | EVP, Head of Tech. Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 6,159 | 61,373 (0%) | 0% | 0 | Common Stock | |
| Incyte | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.88 per share. | 19 Jan 2023 | 105 | 55,214 (0%) | 0% | 83.9 | 8,807 | Common Stock |
| Incyte | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.26 per share. | 15 Jan 2023 | 87 | 55,319 (0%) | 0% | 81.3 | 7,070 | Common Stock |
| Incyte | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.26 per share. | 15 Jan 2023 | 87 | 55,406 (0%) | 0% | 81.3 | 7,070 | Common Stock |
| Incyte | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.08 per share. | 04 Jan 2023 | 117 | 55,493 (0%) | 0% | 79.1 | 9,252 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.71 per share. | 15 Nov 2022 | 23,304 | 446,665 (0%) | 0% | 16.7 | 389,410 | Common Stock |
| Vera Therapeutics Inc (Class A) | Michael M. Morrissey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Selective Insurance Grp Inc | Michael J. Morrissey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2022 | 1,727 | 16,566 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 270,415 | 399,271 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Mar 2022 | 50,000 | 1,196,316 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.59 per share. | 15 Feb 2022 | 59,044 | 128,856 (0%) | 0% | 18.6 | 1,097,628 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.59 per share. | 15 Feb 2022 | 6,103 | 187,900 (0%) | 0% | 18.6 | 113,455 | Common Stock |
| Incyte | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.35 per share. | 24 Jan 2022 | 78 | 55,610 (0%) | 0% | 75.3 | 5,877 | Common Stock |
| Incyte | Michael James Morrissey | EVP, Head of Tech. Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 6,959 | 55,688 (0%) | 0% | 0 | Common Stock | |
| Incyte | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.01 per share. | 18 Jan 2022 | 101 | 48,830 (0%) | 0% | 75.0 | 7,576 | Common Stock |